Growth Metrics

Emergent BioSolutions (EBS) Divestments (2023)

Emergent BioSolutions' Divestments history spans 1 years, with the latest figure at $74.9 million for Q2 2023.

  • For Q2 2023, Divestments changed N/A year-over-year to $74.9 million; the TTM value through Dec 2024 reached $74.9 million, changed 0.0%, while the annual FY2024 figure was $110.2 million, 59.22% down from the prior year.
  • Divestments reached $74.9 million in Q2 2023 per EBS's latest filing.
  • In the past five years, Divestments ranged from a high of $74.9 million in Q2 2023 to a low of $74.9 million in Q2 2023.